FRIDAY, Nov. 21, 2025 (HealthDay News) — Pfizer’s mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the results of a clinical trial.

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

Among patients hospitalized with severe influenza, those with A(H1N1) have more high-risk clinical indicators vs those with other subtypes.

Study shows high-dose vaccines work better for older adults while cell-based versions benefit younger people as respiratory ...

Countless studies have shown no link between vaccines and an increased risk of autism spectrum disorder. Many large studies from around the world show there is no link between vaccines and autism.

A new H3N2 flu variant, subclade K, is spreading in the US, with concerns about its resistance to this year's flu vaccine and ...

Chinese vaccine company Sinovac Biotech Ltd has announced that the age indications for its trivalent and quadrivalent ...

As the holiday season rapidly approaches, it’s important to remember that we are also now heading into peak season for ...

A team of researchers at the University of Pittsburgh has developed a skin patch that can detect antibodies associated with ...